We suppose that it is because pharmaceutical companies do not have what we call blockbuster medicines that they can sell at high prices and so they are simply bringing minute changes to their existing medicines. They want to give some return to their shareholders. So they are sort of sending trial balloons, so to speak. There certainly was a climate change in the pharmaceutical industry. This may be encouraged by parent companies in the United States, but we do not know for sure.
On March 28th, 2007. See this statement in context.